| Drug Name |
Rimabotulinumtoxinb |
| Drug ID |
BADD_D01943 |
| Description |
Neurotoxin produced by fermentation of clostridium botulinum type B. The protein exists in noncovalent association with hemagglutinin and nonhemagglutinin proteins as a neurotoxin complex. The neurotoxin complex is recovered from the fermentation process and purified through a series of precipitation and chromatography steps. |
| Indications and Usage |
For the treatment of patients with cervical dystonia to reduce the severity of abnormal head position and neck pain associated with cervical dystonia. |
| Marketing Status |
approved; investigational |
| ATC Code |
Not Available |
| DrugBank ID |
DB00042
|
| KEGG ID |
D02735
|
| MeSH ID |
C096323
|
| PubChem ID |
Not Available
|
| TTD Drug ID |
D02FXK
|
| NDC Product Code |
10454-711; 10454-712; 10454-710 |
| UNII |
0Y70779M1F
|
| Synonyms |
rimabotulinumtoxinB | rimabotulinum toxin B | rimabotulinumtoxin B | NeuroBloc | botulinum B toxin | botulinum toxin type B | botulinum neurotoxin B | Clostridium botulinum B toxin | Myobloc |
